Resistance of Nonmelanoma Skin Cancer to Nonsurgical Treatments. Part I: Topical Treatments
Authors:
- T. Gracia-CazañaTGT. Gracia-Cazaña
- S. GonzálezSGS. González
- Y. GilaberteYGY. Gilaberte
Open Access
- 1 November 2016
- journal article
- Published by Elsevier in Actas Dermo-Sifiliograficas
- Vol. 107 (9) , 730-739
Abstract
No abstract availableThis publication has 55 references indexed in Scilit:
- Targeting hedgehog signaling in cancer: research and clinical developmentsOncoTargets and Therapy, 2013
- Topical and Intralesional Treatment of Nonmelanoma Skin Cancer: Efficacy and Cost ComparisonsDermatologic Surgery, 2013
- New developments in the treatment of actinic keratosis: focus on ingenol mebutate gelClinical, Cosmetic and Investigational Dermatology, 2012
- Ingenol Mebutate Gel for Actinic KeratosisNew England Journal of Medicine, 2012
- Cicatricial ectropion: A complication of topical 5-fluorouracilJournal of Plastic, Reconstructive & Aesthetic Surgery, 2012
- Ensayo clínico: la infiltración intralesional con metotrexato de forma neoadyuvante en la cirugía del queratoacantoma permite obtener mejores resultados estéticos y funcionalesActas Dermo-Sifiliograficas, 2011
- Co-overexpression of Bag-1 and heat shock protein 70 in human epidermal squamous cell carcinoma: Bag-1-mediated resistance to 5-fluorouracil-induced apoptosisBritish Journal of Cancer, 2011
- Topical Imiquimod or Fluorouracil Therapy for Basal and Squamous Cell CarcinomaArchives of Dermatology, 2009
- Terapia fotodinámica: nuevas indicacionesActas Dermo-Sifiliograficas, 2007
- Two cases of Bowen's disease successfully treated topically with 3% diclofenac in 2.5% hyaluronan gelClinical and Experimental Dermatology, 2005